AMYLIN PHARMACEUTICALS INC: current_assets

Value{"amount": 570876000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"}
Period (as of 2012-06-30)
Statuscurrent
EntityAMYLIN PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000881464-12-000017 · Open the official SEC filing →
Retrieved: 2026-08-19T08:48:02.716993+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000881464/current-assets/2012-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/69bf668d-fe11-42d9-b10a-9a50c93338cc

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies